Saturday, December 13, 2025 | 10:05 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India delays Covid vaccine supplies to WHO-backed COVAX: Report

The world's biggest vaccine maker resumed exports of COVID-19 doses this month for the first time since April.

India too had opened diplomatic dialogues with the European Union (EU) after the EU Digital Covid Certificate framework recognised the AstraZeneca-Oxford vaccine, but not Covishield.
premium

Reuters
India has delayed committing supplies of vaccine to the COVAX global sharing platform, two sources told Reuters on Tuesday, a day after one of its key backers, the WHO, said the agency could not "cut corners" to approve a domestically developed vaccine.

The world's biggest vaccine maker resumed exports of COVID-19 doses this month for the first time since April. It has sent about 4 million to countries such as neighbouring Bangladesh and Iran, but none to COVAX.

On Monday, in the run-up to an Oct. 26 meeting on Covaxin, India's first domestically developed COIVD-19 vaccine, the World Health Organization (WHO) said

Disclaimer: No Business Standard Journalist was involved in creation of this content